These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33467659)

  • 21. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
    Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
    FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
    Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
    Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
    Zhang Y; Li H; Hao J; Zhou Y; Liu W
    Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of SETD6 protects podocyte against high glucose and palmitic acid-induced apoptosis, and mitochondrial dysfunction via activating Nrf2-Keap1 signaling pathway in diabetic nephropathy.
    Wang X; Liu Q; Kong D; Long Z; Guo Y; Wang S; Liu R; Hai C
    J Mol Histol; 2020 Oct; 51(5):549-558. PubMed ID: 32803470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
    Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
    Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Podocytes as a target of insulin.
    Coward RJ; Saleem MA
    Curr Diabetes Rev; 2011 Jan; 7(1):22-7. PubMed ID: 21067503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
    Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
    Zhang L; Wen Z; Han L; Zheng Y; Wei Y; Wang X; Wang Q; Fang X; Zhao L; Tong X
    J Diabetes Res; 2020; 2020():7504798. PubMed ID: 32695831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
    Guo K; Pan P; Wu M; Ma Y; Lu J; Chen H
    Mol Cell Endocrinol; 2020 Apr; 505():110730. PubMed ID: 31981598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sam68 mediates high glucose‑induced podocyte apoptosis through modulation of Bax/Bcl‑2.
    Chen Y; Zhang L; Liu S; Yao B; Zhang H; Liang S; Ma J; Liang X; Shi W
    Mol Med Rep; 2019 Oct; 20(4):3728-3734. PubMed ID: 31485651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors.
    Chen X; Wang J; Lin Y; Liu Y; Zhou T
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.